What dose should Invega ER (paliperidone) be increased to from 3 mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Paliperidone ER Dose Increase from 3 mg

When increasing Invega ER (paliperidone) from 3 mg, the dose should be increased to 6 mg once daily, which is the recommended standard dose for adults with schizophrenia and schizoaffective disorder. 1

Dosing Guidelines for Paliperidone ER

Standard Dosing

  • The FDA-approved standard dose for paliperidone ER in adults is 6 mg once daily 1
  • Initial dose titration is not required when starting at 6 mg
  • For patients currently on 3 mg, increasing to 6 mg is the next appropriate step

Dose Adjustment Considerations

  • Dose increases should occur at intervals of more than 5 days for schizophrenia 1
  • For schizoaffective disorder, dose increases should occur at intervals of more than 4 days 1
  • When dose increases are indicated, increments of 3 mg/day are recommended

Maximum Dosing

  • Maximum recommended dose is 12 mg/day 1
  • Although higher doses may provide additional benefit for some patients, this must be weighed against dose-related increases in adverse reactions

Special Populations

Renal Impairment

  • For patients with mild renal impairment (creatinine clearance ≥50 mL/min to <80 mL/min):
    • Initial dose: 3 mg once daily
    • Maximum dose: 6 mg once daily 1
  • For patients with moderate to severe renal impairment (creatinine clearance ≥10 mL/min to <50 mL/min):
    • Initial dose: 1.5 mg once daily
    • Maximum dose: 3 mg once daily 1

Elderly Patients

  • Elderly patients may have diminished renal function requiring dose adjustments
  • For elderly patients with normal renal function, dosing is the same as for younger adults
  • For elderly patients with moderate to severe renal impairment, maximum dose is 3 mg once daily 1

Monitoring and Safety Considerations

Common Adverse Effects

  • Extrapyramidal symptoms (EPS) - incidence increases in a dose-related manner 2
  • Tachycardia
  • Somnolence
  • Headache and insomnia 3

Important Monitoring Parameters

  • Extrapyramidal symptoms
  • Cardiovascular parameters (heart rate, blood pressure, QTc interval)
  • Prolactin levels (paliperidone ER is associated with increases in serum prolactin) 2

Clinical Pearls

  • Paliperidone ER tablets must be swallowed whole with liquids and should not be chewed, divided, or crushed 1
  • Can be taken with or without food
  • Consider the additive paliperidone exposure if risperidone is co-administered with paliperidone ER 1
  • Paliperidone ER follows linear pharmacokinetics at therapeutic doses (3-12 mg) 3
  • The majority (59%) of paliperidone is eliminated through the kidneys as unchanged drug 3

By following these guidelines, you can appropriately increase the dose of Invega ER from 3 mg to 6 mg once daily, with careful monitoring for efficacy and adverse effects.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.